120
Participants
Start Date
February 17, 2023
Primary Completion Date
June 1, 2025
Study Completion Date
June 1, 2025
Bupivacaine
2 mL of bupivacaine 0.5% (5 mg/mL) injected at the origin of each bilateral greater and lesser occipital nerves
Lidocaine
0.5 mL of lidocaine 1% (10 mg/mL) injected at the origin of each bilateral greater and lesser occipital nerves
Dexamethasone
0.5 mL of dexamethasone (10 mg/mL) injected at the origin of each bilateral greater and lesser occipital nerves
Normal saline
0.5 mL of normal saline 0.9% injected at the origin of each bilateral greater and lesser occipital nerves
Greater/lesser occipital nerve blocks
Subjects will receive a total of 12 mL injectate divided equally between the 4 injection sites of the bilateral greater and lesser occipital nerves using the landmark-based technique.
Mayo Clinic Minnesota, Rochester
Lead Sponsor
Mayo Clinic
OTHER